Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

EVFM Evofem Biosciences

Watchlist
0.080
+0.001+1.27%
Close  12/09 16:00 ET
High
0.085
Open
0.080
Turnover
126.67K
Low
0.064
Pre Close
0.079
Volume
1.65M
Market Cap
3.38M
P/E(TTM)
Loss
52wk High
8.100
Shares
42.20M
P/E(Static)
Loss
52wk Low
0.055
Float Cap
3.03M
Bid/Ask %
0.00%
Historical High
188.400
Shs Float
37.89M
Volume Ratio
1.43
Historical Low
0.055
Dividend TTM
--
Div Yield TTM
--
P/B
-0.02
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
4.36%
Amplitude
26.52%
Avg Price
0.076
Lot Size
1
Float Cap
3.03M
Bid/Ask %
0.00%
Historical High
188.400
Shs Float
37.89M
Volume Ratio
1.43
Historical Low
0.055
Dividend TTM
--
P/B
-0.02
Dividend LFY
--
Turnover Ratio
4.36%
Amplitude
26.52%
Avg Price
0.076
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
CEO: Ms. Saundra Pelletier
Market: Pink Market
Listing Date: 11/20/2014
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist